EVI to co-lead new CEPI project with University of Tokyo to develop vaccine against Nipah virus

CEPI awards contract worth up to US$ 31 million to develop vaccine against Nipah virus.

The Coalition for Epidemic Preparedness Innovations (CEPI) and The University of Tokyo have announced a partnering agreement worth up to US$ 31 million to advance the development and manufacture of a vaccine against the Nipah virus—a bat-borne virus that can spread to both humans and livestock. The new project will be co-led by EVI.
 For full news story, please follow this link.